Studies have also reported that ZNF165 is frequently expressed in human urinary bladder transitional cell carcinoma, which is confirmed as a novel diagnostic biomarker and a vaccine target in urinary bladder cancer [85]. Here, ZNF165 is linked to bladder transitional cell carcinoma.